Bulk Manufacturer of Controlled Substances Registration, 56103 [2018-24484]

Download as PDF 56103 Federal Register / Vol. 83, No. 218 / Friday, November 9, 2018 / Notices On March 27, 2012, 3D PDF filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on April 20, 2012 (77 FR 23754). The last notification was filed with the Department on August 15, 2018. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on September 4, 2018 (83 FR 44904). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2018–24542 Filed 11–8–18; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Registration ACTION: Notice of registration. The registrant listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I and II controlled substances. SUPPLEMENTARY INFORMATION: The company listed below applied to be registered as bulk manufacturer of various basic classes of controlled substances. Information on the previously published notice is listed in the table below. No comments or objections were submitted for this notice. SUMMARY: Company FR citation Euticals Inc ... 83 FR 39129 Published August 8, 2018. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of this registrant to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed company. Dated: October 29, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018–24484 Filed 11–8–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 8, 2019. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on August 2, 2018, Chattem Chemicals, 3801 Saint Elmo Avenue, Chattanooga, Tennessee 37409–1237 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: khammond on DSK30JT082PROD with NOTICES Controlled substance Drug code Gamma Hydroxybutyric Acid ................................................................................................................................... Marihuana ................................................................................................................................................................ Tetrahydrocannabinols ............................................................................................................................................ 4-Methoxyamphetamine .......................................................................................................................................... Dihydromorphine ..................................................................................................................................................... Amphetamine .......................................................................................................................................................... Methamphetamine ................................................................................................................................................... Lisdexamfetamine ................................................................................................................................................... Methylphenidate ...................................................................................................................................................... Codeine ................................................................................................................................................................... Dihydrocodeine ........................................................................................................................................................ Oxycodone .............................................................................................................................................................. Hydromorphone ....................................................................................................................................................... Hydrocodone ........................................................................................................................................................... Levorphanol ............................................................................................................................................................. Methadone ............................................................................................................................................................... Methadone intermediate .......................................................................................................................................... Morphine .................................................................................................................................................................. Oripavine ................................................................................................................................................................. Thebaine .................................................................................................................................................................. Oxymorphone .......................................................................................................................................................... Noroxymorphone ..................................................................................................................................................... VerDate Sep<11>2014 17:36 Nov 08, 2018 Jkt 247001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\09NON1.SGM 09NON1 2010 7360 7370 7411 9145 1100 1105 1205 1724 9050 9120 9143 9150 9193 9220 9250 9254 9300 9330 9333 9652 9668 Schedule I I I I I II II II II II II II II II II II II II II II II II

Agencies

[Federal Register Volume 83, Number 218 (Friday, November 9, 2018)]
[Notices]
[Page 56103]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24484]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrant listed below has applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as a bulk 
manufacturer of various classes of schedule I and II controlled 
substances.

SUPPLEMENTARY INFORMATION: The company listed below applied to be 
registered as bulk manufacturer of various basic classes of controlled 
substances. Information on the previously published notice is listed in 
the table below. No comments or objections were submitted for this 
notice.

------------------------------------------------------------------------
             Company                  FR citation          Published
------------------------------------------------------------------------
Euticals Inc....................  83 FR 39129.......  August 8, 2018.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of this registrant to manufacture the 
applicable basic classes of controlled substances is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer 
to the above listed company.

    Dated: October 29, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-24484 Filed 11-8-18; 8:45 am]
 BILLING CODE 4410-09-P